Oliver Ottmann

12PUBLICATIONS
34CO-AUTHORS
Child and adolescent developmentHaematological tumoursMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 31, 2024
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.

Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti

|Oct 26, 2022
Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation.

Claudia Chiriches, Nathalie Nicolaisen, Maria Wieske

|Aug 08, 2022
Activation of signaling pathways in models of t(6;9)-acute myeloid leukemia.

Claudia Chiriches, Dilawar Khan, Maria Wieske

|Apr 12, 2022
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial.

Marina Y Konopleva, Christoph Röllig, Jamie Cavenagh

|Jan 20, 2018
Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation.

Heike Pfeifer, Katharina Raum, Sandra Markovic

|Nov 11, 2017
CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells.

Mateusz Legut, Garry Dolton, Afsar Ali Mian

Pageof 2

Frequent Collaborators

2 joint publications

Philippe Rousselot

2 joint publications

Hartmut Döhner

2 joint publications

Claudia Chiriches

2 joint publications

Maria Wieske